We are dedicated to investing in highly innovative, early stage biotechnology companies. We are focused on supporting the development of novel therapeutics for unmet medical needs.
Rob hopfner, rph, PhD, MBA
KAROLY NIKOLICH, PHD
ash khanna, PHD
Jim trenkle, PHD
Pivotal bioVenture Partners supports teams that develop therapeutics that make a difference in patients' lives. Are you one of those teams? We'd love to hear from you.